Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
Autor: | Stefanie P. Ferreri, Debbie Hiller, Natasha M. Michaels, Ashley N. Hannings, Macary Weck Marciniak |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Pharmacist Insulin delivery insulin vial lcsh:RS1-441 030209 endocrinology & metabolism insulin pen delivery systems Vial Pharmacy Practice lcsh:Pharmacy and materia medica 03 medical and health sciences 0302 clinical medicine medicine community pharmacy In patient 030212 general & internal medicine Medical prescription Original Research Community based business.industry Insulin Insulin pen Emergency medicine insulin administration business insulin syringe |
Zdroj: | INNOVATIONS in Pharmacy, Vol 10, Iss 3 (2019) Innovations in Pharmacy |
ISSN: | 2155-0417 |
Popis: | Objective: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. Methods: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contacted by community-based pharmacists during a five-month period and were informed of the availability and potential benefits of insulin pen delivery systems (IPDS). If the patient agreed to the switch, the pharmacist contacted the prescriber to obtain a new prescription. Prescription refill records were tracked for six months post-intervention to determine whether patients who were converted remained on the IPDS. Results: The overall vial-to-pen conversion success rate was 26% out of 121 potential conversions. In addition, 52% of patients reached were willing to switch and prescribers approved 71% of the recommendations to switch from vial-to-pen. Of the prescriptions successfully converted to an IPDS, 84% of prescriptions were still dispensed as pen products six months following the conversion. Conclusion: Community-based pharmacists can serve as a resource to provide education on insulin delivery options and increase use of IPDS in patients with diabetes. Treatment of Human Subjects: IRB review/approval required and obtained Article Type: Original Research |
Databáze: | OpenAIRE |
Externí odkaz: |